| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |